NS
GILD icon

NBC Securities’s Gilead Sciences GILD Stock Holding History

NBC Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.17M Sell
17,146
-129
-0.7% -$17K 0.15% 158
2026
Q1 		$2.41M Buy
17,275
+128
+0.7% +$17.9K 0.18% 130
2025
Q4 		$2.1M Buy
17,147
+10,295
+150% +$1.25M 0.16% 145
2025
Q3 		$761K Sell
6,852
-94
-1% -$10.7K 0.06% 352
2025
Q2 		$770K Sell
6,946
-1,551
-18% -$165K 0.06% 347
2025
Q1 		$952K Buy
8,497
+8,483
+60,593% +$875K 0.08% 259
2024
Q4 		$1.31K Sell
14
-16,469
-100% -$1.48M 0.12% 190
2024
Q3 		$1.38M Buy
16,483
+428
+3% +$32.7K 0.12% 183
2024
Q2 		$1.1M Sell
16,055
-159
-1% -$10.6K 0.1% 219
2024
Q1 		$1.19M Buy
16,214
+187
+1% +$14.4K 0.11% 202
2023
Q4 		$1.3M Buy
16,027
+54
+0.3% +$4.2K 0.13% 151
2023
Q3 		$1.2M Buy
+15,973
New +$1.23M 0.13% 152

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NBC Securities's GILD Position: Q2 2026 in Review

NBC Securities reduced its Gilead Sciences (GILD) stake by 0.75% in Q2 2026, selling an estimated $17K and leaving 17,146 shares worth $2.17M. The position accounts for 0.15% of the portfolio, ranked #158.

NBC Securities first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.41M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • NBC Securities held 17,146 shares of Gilead Sciences worth $2.17M as of Q2 2026.
  • NBC Securities sold 129 Gilead Sciences shares in Q2 2026, an estimated $17K.
  • Gilead Sciences made up 0.15% of NBC Securities's portfolio in Q2 2026, its #158 holding.
  • NBC Securities first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's Gilead Sciences position peaked at $2.41M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.